Combination of tumor markers predicts progression and pathological response in patients with locally advanced gastric cancer after neoadjuvant chemotherapy treatment
出版年份 2021 全文链接
标题
Combination of tumor markers predicts progression and pathological response in patients with locally advanced gastric cancer after neoadjuvant chemotherapy treatment
作者
关键词
-
出版物
BMC GASTROENTEROLOGY
Volume 21, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-07-10
DOI
10.1186/s12876-021-01785-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The clinical value and usage of inflammatory and nutritional markers in survival prediction for gastric cancer patients with neoadjuvant chemotherapy and D2 lymphadenectomy
- (2020) Ziyu Li et al. Gastric Cancer
- Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer
- (2020) Yong-He Chen et al. WORLD JOURNAL OF GASTROENTEROLOGY
- A Modified ypTNM Staging System–Development and External Validation of a Nomogram Predicting the Overall Survival of Gastric Cancer Patients Received Neoadjuvant Chemotherapy
- (2020) Ziyu Li et al. Cancer Management and Research
- Which is the optimal management for locally advanced gastric cancer patients with TRG 0 and 1 after R0 resection?
- (2020) Fei Ma et al. Annals of Translational Medicine
- Perioperative Treatment in Resectable Gastric Cancer: Current Perspectives and Future Directions
- (2019) Angelica Petrillo et al. Cancers
- The Prognostic Value of a Pathologic Complete Response After Neoadjuvant Therapy for Digestive Cancer: Systematic Review and Meta-Analysis of 21 Studies
- (2019) Tao Wan et al. ANNALS OF SURGICAL ONCOLOGY
- Clinical Evaluation of CA72-4 for Screening Gastric Cancer in A Healthy Population: A Multicenter Retrospective Study
- (2019) Hu et al. Cancers
- Varying practices in tumor regression grading of gastrointestinal carcinomas after neoadjuvant therapy: results of an international survey
- (2019) Maria Westerhoff et al. MODERN PATHOLOGY
- Preoperative Tumor Markers Independently Predict Survival in Stage III Gastric Cancer Patients: Should We Include Tumor Markers in AJCC Staging?
- (2018) Jian-Xian Lin et al. ANNALS OF SURGICAL ONCOLOGY
- ypTNM staging after neoadjuvant chemotherapy in the Chinese gastric cancer population: an evaluation on the prognostic value of the AJCC eighth edition cancer staging system
- (2018) Ziyu Li et al. Gastric Cancer
- Correlation of pathological complete response with survival after neoadjuvant chemotherapy in gastric or gastroesophageal junction cancer treated with radical surgery: A meta-analysis
- (2018) Ziyu Li et al. PLoS One
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial
- (2017) Derek Alderson et al. LANCET ONCOLOGY
- A novel classifier based on three preoperative tumor markers predicting the cancer-specific survival of gastric cancer (CEA, CA19-9 and CA72-4)
- (2017) Jing Guo et al. Oncotarget
- Serum CA19-9 as a marker of circulating tumor cells in first reflux blood of colorectal cancer patients
- (2017) Jia-Xing Zhao et al. Oncotarget
- Japanese gastric cancer treatment guidelines 2014 (ver. 4)
- (2016) Gastric Cancer
- Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial
- (2016) Elizabeth C. Smyth et al. JOURNAL OF CLINICAL ONCOLOGY
- Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology
- (2016) Jaffer A. Ajani et al. Journal of the National Comprehensive Cancer Network
- Combined preoperative concentrations of CEA, CA 19-9, and 72-4 for predicting outcomes in patients with gastric cancer after curative resection
- (2016) Xuechao Liu et al. Oncotarget
- Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma
- (2016) Wei Wang et al. Oncotarget
- Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy
- (2015) Zhipeng Sun et al. World Journal of Surgical Oncology
- Events per variable (EPV) and the relative performance of different strategies for estimating the out-of-sample validity of logistic regression models
- (2014) Peter C Austin et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Induction of a Pathological Complete Response by Four Courses of Neoadjuvant Chemotherapy for Gastric Cancer: Early Results of the Randomized Phase II COMPASS Trial
- (2013) Takaki Yoshikawa et al. ANNALS OF SURGICAL ONCOLOGY
- Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks
- (2013) Paul Blanche et al. STATISTICS IN MEDICINE
- Correlation between serum CA724 and gastric cancer: multiple analyses based on Chinese population
- (2012) Xin-Zu Chen et al. MOLECULAR BIOLOGY REPORTS
- Significance of Histopathological Tumor Regression After Neoadjuvant Chemotherapy in Gastric Adenocarcinomas
- (2011) Karen Becker et al. ANNALS OF SURGERY
- Further evidence of the prognostic role of pretreatment levels of CA 19-9 in advanced pancreatic cancer
- (2010) Everardo D. Saad et al. Revista da Associacao Medica Brasileira
- Chemotherapy-induced transient CEA and CA19-9 surges in patients with metastatic or recurrent gastric cancer
- (2008) Hye Jin Kim et al. ACTA ONCOLOGICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now